肌炎自身抗体免疫检测的可靠性取决于抗体特异性
该研究比较两种商业免疫检测与放射标记蛋白免疫沉淀法检测肌炎特异性及相关性自身抗体的结果,发现总体一致性较高(Cohen's κ >0.8),但罕见抗合成酶抗体(κ <0.2)和抗TIF1γ抗体检测可靠性差,且假阳性率分别为13.7%(线印迹)和12.1%(斑点印迹)。结论提示临床医生需了解本地实验室方法的局限性,必要时仍应选择免疫沉淀法。
要点
- 商业免疫检测对多数肌炎抗体一致性高,但罕见抗合成酶和抗TIF1γ抗体可靠性差。
- 抗TIF1γ可能识别构象表位,变性抗原的印迹法检测能力受限。
- 线印迹和斑点印迹的假阳性率分别为13.7%和12.1%,临床解读需结合语境。
核心结论
- 所分析的商业免疫检测并非对所有肌炎特异性及相关性自身抗体均表现良好,总体假阳性较常见。
- 临床医生必须了解本地实验室所用方法的局限性,结果需结合临床背景解读,疑似抗合成酶综合征但抗体阴性者仍应考虑免疫沉淀法。
研究设计与样本
- 以放射标记蛋白免疫沉淀法为参考,对转诊至实验室进行肌炎自身抗体鉴定的患者血清进行检测。
- 每种目标自身抗体选取25例不同患者血清,分别用线印迹(Euroline Myositis Antigen Profile 4)和斑点印迹(D-Tek BlueDiver)分析,并检测134例成人健康对照血清。
主要发现
- 商业检测总体表现尚可,一致性高(Cohen's κ >0.8)。
- 罕见抗合成酶抗体检测的κ <0.2,抗TIF1γ检测的κ在线印迹为0.70、斑点印迹为0.31。
- 线印迹分析样本中13.7%出现假阳性,斑点印迹分析样本中12.1%出现假阳性。
- 进一步分析提示抗TIF1γ患者比例可能识别构象表位,限制了使用变性抗原的印迹法检测该临床重要自身抗体的能力。
关键数值与推荐
- 总体一致性以Cohen's κ >0.8为高。
- 罕见抗合成酶抗体检测κ <0.2。
- 抗TIF1γ检测κ:线印迹0.70,斑点印迹0.31。
- 假阳性率:线印迹13.7%,斑点印迹12.1%。
临床怎么用
- 临床解读肌炎自身抗体商业检测结果时需结合患者临床背景,并了解本地实验室方法的局限性。
- 对疑似抗合成酶综合征但抗体阴性的患者,仍应考虑免疫沉淀法检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In order to address the reliability of commercial assays to identify myositis-specific and -associated autoantibodies, we aimed to compare the results of two commercial immunoassays with the results obtained by protein immunoprecipitation. METHODS: Autoantibody status was determined using radio-labelled protein immunoprecipitation for patients referred to our laboratory for myositis autoantibody characterization. For each autoantibody of interest, the sera from 25 different patients were analysed by line blot (Euroline Myositis Antigen Profile 4, EuroImmun, Lübeck, Germany) and dot blot (D-Tek BlueDiver, Diagnostic Technology, Belrose, NSW, Australia). Sera from 134 adult healthy controls were analysed. RESULTS: Overall commercial assays performed reasonably well, with high agreement (Cohen's κ >0.8). Notable exceptions were the detection of rarer anti-synthetases with κ < 0.2 and detection of anti-TIF1γ, where κ was 0.70 for the line blot and 0.31 for dot blot. Further analysis suggested that the proportion of patients with anti-TIF1γ may recognize a conformational epitope, limiting the ability of blotting-based assays that utilize denatured antigen to detect this clinically important autoantibody. A false-positive result occurred in 13.7% of samples analysed by line blot and 12.1% analysed by dot blot. CONCLUSION: The assays analysed do not perform well for all myositis-specific and -associated autoantibodies and overall false positives are relatively common. It is crucial that clinicians are aware of the limitations of the methods used by their local laboratory. Results must be interpreted within the clinical context and immunoprecipitation should still be considered in selected cases, such as apparently autoantibody-negative patients where anti-synthetase syndrome is suspected.
引用
- Tansley SL, Li D, Betteridge ZE, et al. The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity. Rheumatology (Oxford). 2020. PMID: 32030410. doi:10.1093/rheumatology/keaa021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。